PATENT CLAIM ANALYSIS

Application Number: 16040871
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "001730"]

Abstract:
The present invention relates to a biocompatible nanoparticle and a use thereof and, more specifically, to a biocompatible nanoparticle formed by irradiation an electron beam to an aqueous solution comprising at least one substance selected from the group consisting of a polysaccharide, a derivative thereof and a polyethylene glycol, thereby inducing inter-molecular cross-linking or intra-molecular cross-linking, and to a use of the biocompatible nanoparticle in a drug carrier, a contrast agent, a diagnostic agent or an intestinal adhesion prevention agent or for disease prevention and treatment.

Claim (Index 12):
A contrast agent composition comprising the nanoparticle of  claim 1  and a pharmaceutically acceptable carrier or additive, wherein the nanoparticle is labeled with at least one labeling material selected from the group consisting of radioactive isotopes, organic fluorescent dyes, quantum dots as inorganic materials, magnetic resonance imaging (MRI) contrast agents, computed tomography (CT) contrast agents, positron emission tomography (PET) contrast agents, ultrasound contrast agents, and fluorescent contrast agents.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 95.0
- Lexical Diversity: 1.67857
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13123428', '14726770', '12338966', '14410521', '15069311']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.709144561024011
- 35 USC 102 Novelty (BERT): 0.5034952759900044
- Combined Prediction Score: 0.6885796325206104
- Mean Citation Score: 240.063162
- Max Citation Score: 255.64731
- Similarity Product: 177.3524779451591

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test